ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 580,03
-0,69%
Dow Jones
40 792,58
1,44%
DAX
18 518,03
-0,44%
Brent Oil
83,50
-1,00%
Bitcoin
64 375,57
-0,73%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Teva Pharmaceutical Industries Ltd (TEVA)

  7. Teva Pharmaceutical Industries Ltd (TEVA) Actualités

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:TEVA
DateHeureSourceTitreSymboleSociété
07/06/201621h33Business WireTeva Gains Recommendation for Approval from FDA Advisory Committees for VANTRELA™ ER (hydrocodone bitartrate) Extended-Rele...NYSE:TEVATeva Pharmaceutical Industries Ltd
07/06/201614h11Edgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:TEVATeva Pharmaceutical Industries Ltd
07/06/201614h00Business WireTeva to Present at the Jefferies 2016 Healthcare ConferenceNYSE:TEVATeva Pharmaceutical Industries Ltd
06/06/201614h00Business WireTeva to Present at the Goldman Sachs 37th Annual Global Healthcare ConferenceNYSE:TEVATeva Pharmaceutical Industries Ltd
31/05/201622h11Edgar (US Regulatory)Specialized Disclosure Report (sd)NYSE:TEVATeva Pharmaceutical Industries Ltd
31/05/201618h29Dow Jones NewsFDA Rejects Teva's Application for Huntington's Drug -- 3rd UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
31/05/201615h10Dow Jones NewsFDA Rejects Teva's Application For Huntington's DrugNYSE:TEVATeva Pharmaceutical Industries Ltd
31/05/201615h07Dow Jones NewsFDA Rejects Teva's Application for Huntington's Drug -- 2nd UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
31/05/201614h54Dow Jones NewsFDA Asks Teva for More Information on Huntington's Drug -- UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
31/05/201614h39Dow Jones NewsFDA Asks Teva for More Information on Huntington's DrugNYSE:TEVATeva Pharmaceutical Industries Ltd
31/05/201614h00Business WireTeva to Present at the Bernstein 32nd Annual Strategic Decisions ConferenceNYSE:TEVATeva Pharmaceutical Industries Ltd
31/05/201613h00Business WireTeva Receives Complete Response Letter for NDA for SD-809 for the Treatment of Chorea Associated with Huntington DiseaseNYSE:TEVATeva Pharmaceutical Industries Ltd
30/05/201619h00PR Newswire (US)Teva Achieves Positive Conclusion for the European Decentralised Procedure (DCP) for BRALTUS® (tiotropium bromide)NYSE:TEVATeva Pharmaceutical Industries Ltd
18/05/201614h30PR Newswire (US)Emerald Medical Applications Corp (OTCQB: MRLA) Appoints Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to its Scientific...NYSE:TEVATeva Pharmaceutical Industries Ltd
17/05/201614h40Dow Jones NewsAstraZeneca Asthma Drug Shows Positive ResultsNYSE:TEVATeva Pharmaceutical Industries Ltd
12/05/201614h00Business WireTeva to Present New Data at the 2016 American Thoracic Society (ATS) International ConferenceNYSE:TEVATeva Pharmaceutical Industries Ltd
10/05/201614h10Dow Jones NewsAllergan Realigns Executive Team, Outlines $10 Billion Stock BuybackNYSE:TEVATeva Pharmaceutical Industries Ltd
10/05/201612h45GlobeNewswire Inc.Adamis Pharmaceuticals Announces License Agreement with Allergan plc Subsidiary for Epinephrine Pre-Filled SyringeNYSE:TEVATeva Pharmaceutical Industries Ltd
09/05/201617h00Business WireTeva to Present at the Bank of America Merrill Lynch 2016 Health Care ConferenceNYSE:TEVATeva Pharmaceutical Industries Ltd
09/05/201615h49Dow Jones NewsU.S. Hot Stocks: Hot Stocks to WatchNYSE:TEVATeva Pharmaceutical Industries Ltd
09/05/201614h40Dow Jones NewsTeva Revenue Declines as Some Drugs Lose ExclusivityNYSE:TEVATeva Pharmaceutical Industries Ltd
09/05/201613h00Business WireTeva Reports First Quarter 2016 ResultsNYSE:TEVATeva Pharmaceutical Industries Ltd
04/05/201618h36PR Newswire (US)Teva Breathes Its Way to a Guinness World Records TitleNYSE:TEVATeva Pharmaceutical Industries Ltd
29/04/201614h00Business WireTeva Announces FDA Approval of ProAir RespiClick® (albuterol sulfate) Inhalation Powder for Pediatric Asthma Patients Ages 4...NYSE:TEVATeva Pharmaceutical Industries Ltd
25/04/201614h00Business WireJennifer Morrison Reveals How Her Journey with Migraine is More Than a HeadacheNYSE:TEVATeva Pharmaceutical Industries Ltd
18/04/201614h30Business WireTeva to Report First Quarter 2016 Financial Results on May 9, 2016NYSE:TEVATeva Pharmaceutical Industries Ltd
18/04/201614h00Business WireTeva Presents New Data for SD-809 in Huntington Disease at 68th American Academy of Neurology (AAN) Annual Meeting in Vancouv...NYSE:TEVATeva Pharmaceutical Industries Ltd
12/04/201614h00Business WireTeva to Present Data Highlighting Company’s Pipeline in Neurological Disorders at 68th AAN Annual MeetingNYSE:TEVATeva Pharmaceutical Industries Ltd
07/04/201615h00Dow Jones NewsAllergan Completes Licensing Deal After Pfizer Bid CollapsesNYSE:TEVATeva Pharmaceutical Industries Ltd
01/04/201601h30Business WireTakeda and Teva Establish “Teva Takeda Yakuhin Ltd.” in JapanNYSE:TEVATeva Pharmaceutical Industries Ltd
 Showing the most relevant articles for your search:NYSE:TEVA

Dernières Valeurs Consultées

EU
VIV
Vivendi
EU
PX1
CAC 40
EU
LR
Legrand
EU
EN
Bouygues
EU
AF
Air FranceKLM
NYSE
JPM
JP Morgan Chase
EU
ORA
Orange
COIN
ETHUSD
Ethereum
EU
CAP
Capgemini
EU
RI
Pernod Ricard
EU
BNP
BNP Paribas
EU
CS
Axa
NYSE
KO
Coca Cola
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés